Psychiatry & Mental Health
-
Stanford Medicine researchers find that ibogaine, a plant-based psychoactive compound, safely led to improvements in depression, anxiety and functioning among veterans with traumatic brain injuries.
-
Brain stimulation can improve hypnotizability
Stanford Medicine scientists used transcranial magnetic stimulation to temporarily enhance hypnotizability in patients with chronic pain, making them better candidates for hypnotherapy.
-
Human Neural Circuitry program
Stanford Medicine’s Karl Deisseroth has created a super-charged, multidisciplinary in-patient research program and laboratory to better understand neuropsychiatric disorders — and share those discoveries with the world.
-
Neural basis for “sunk cost” pride
It may not be smart, but we value something more if we’ve put a lot of sweat equity into it. Neuroscientists may have figured out the biochemical basis of why.
-
How ketamine treats depression
In an unusual trial, Stanford Medicine researchers found that a patient’s belief that they had received ketamine, even if they didn’t, could improve their depression.
-
Virtual reality therapy for hoarding disorder
A first-of-its-kind study by Stanford Medicine researchers lets patients practice letting go of treasured objects in simulations of their own homes.
-
Less sleep, activity linked to prematurity
Data from wearables show that deviations from normal sleep and activity in pregnancy are connected to a risk for premature delivery, a Stanford Medicine-led study found.
-
Jumble of autism genes categorized
Combining two cutting-edge technologies, researchers revealed the impact of a multitude of genes that are associated with neurodevelopmental disorders, including autism, but whose effects on human brain development were previously unknown.
-
Role for ‘junk DNA’
Changes to short, repetitive sequences in the genome have been linked to diseases like autism and schizophrenia. New revelations about how such changes increase and decrease gene expression may provide insight into these and other disorders.
-
Depression after stroke
Scientists discover a biomarker in stroke survivors, suggesting that chemical changes after stroke can lead to depression. The findings may pave the way toward treatment.
-
Gene version cuts Alzheimer’s, Parkinson’s risk
A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
-
Memory in general hindered in autism
Memory impairment in autism goes beyond poor facial recognition, a Stanford Medicine team showed. The finding suggests a wide role for memory in the neurobiology of the disorder.
Psychiatry & Mental Health Topics
- Addiction
- Aging & Geriatrics
- Anesthesiology & Pain Management
- Animal Research
- Artificial Intelligence (AI)
- Autoimmune Conditions
- Awards & Honors
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Diseases
- Innovation & Technology
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health